How many insider trades does FilingIQ track for NVCR?

FilingIQ tracks 1,494 Form 4 insider transactions for NVCR (NovoCure Ltd), covering filings from Oct 2, 2015 onwards. 26 of those were filed in the last 90 days.

Are NVCR insiders net buyers or net sellers?

Across the full Form 4 history for NVCR, 9 transactions (1%) were open-market purchases and 874 (59%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does NVCR insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is NVCR in?

NovoCure Ltd (NVCR) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $1.23B.

NVCR insider trading

NasdaqGS Healthcare

NovoCure Ltd — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

1,494

Last 90 days

Buys / sells

1% / 59%

Market cap

$1.23B

About NovoCure Ltd

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.

Company website: www.novocure.com

NVCR insider activity at a glance

FilingIQ has scored 1,494 insider transactions for NVCR since Oct 2, 2015. The most recent filing in our index is dated Jun 4, 2026.

Across the full history, 9 open-market purchases and 874 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on NVCR insider trades is 58.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live NVCR trades on FilingIQ Raw filings on SEC EDGAR

Latest NVCR Form 4 filings

Leonard Frank X Chief Executive Officer

S Jun 4, 2026

Paravasthu Mukund Chief Operating Officer

S Mar 5, 2026

DOYLE WILLIAM F Executive Chairman

S Mar 3, 2026

Leonard Frank X Chief Executive Officer

S Feb 27, 2026

Cordova Ashley Chief Executive Officer

P Sep 5, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,165

UNITED THERAPEUTICS Corp

APLS 275

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

GH 191

Guardant Health, Inc.

KYMR 178

Kymera Therapeutics, Inc.

First Tracks Biotherapeutics, Inc.

Top insiders trading NVCR

DOYLE WILLIAM F

7 trades · score 71.5

Leonard Frank X

8 trades · score 70.5

Frequently asked

How many insider trades does FilingIQ track for NVCR?: FilingIQ tracks 1,494 Form 4 insider transactions for NVCR (NovoCure Ltd), covering filings from Oct 2, 2015 onwards. 26 of those were filed in the last 90 days.
Are NVCR insiders net buyers or net sellers?: Across the full Form 4 history for NVCR, 9 transactions (1%) were open-market purchases and 874 (59%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does NVCR insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is NVCR in?: NovoCure Ltd (NVCR) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $1.23B.

Methodology & sources

Every NVCR insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.